共 349 条
[1]
Jack CR(2010)Hypothetical model of dynamic biomarkers of the Alzheimer’s pathological cascade Lancet Neurol 9 119-28
[2]
Knopman DS(2010)Cerebrospinal fluid and plasma biomarkers in Alzheimer disease Nat Rev Neurol 6 131-44
[3]
Jagust WJ(2011)The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease Alzheimers Dement 7 263-9
[4]
Shaw LM(2014)Advancing research diagnostic criteria for Alzheimer’s disease: the IWG-2 criteria Lancet Neurol 13 614-29
[5]
Aisen PS(2012)Brain amyloid imaging—FDA approval of Florbetapir F18 injection N Engl J Med 367 885-7
[6]
Weiner MW(2012)Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer’s disease diagnosis: a consensus paper from the Alzheimer’s Biomarkers Standardization Initiative Alzheimers Dement 8 65-73
[7]
Petersen RC(2012)Recommendations to standardize preanalytical confounding factors in Alzheimer’s and Parkinson’s disease cerebrospinal fluid biomarkers: an update Biomark Med 6 419-30
[8]
Trojanowski JQ(2016)Technical performance of a novel, fully automated electrochemiluminescence immuno-assay for the quantitation of β-amyloid (1-42) in human cerebrospinal fluid Alzheimers Dement 12 517-26
[9]
Blennow K(2016)Swedish BioFINDER study group, Hansson O. CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease Ann Clin Transl Neurol 3 154-65
[10]
Hampel H(2016)Cerebrospinal fluid Aβ42/40 corresponds better than Aβ42 to amyloid PET in Alzheimer’s disease J Alzheimers Dis 55 813-22